Patent ID: 8664211
Filing Date: 2014-03-04
Classification: A61K,A61P

Abstract:
1. A method of inhibiting platelet aggregation in a mammal, said method comprising: administering to a mammal with a cardiovascular disorder or a mammal having a blood vessel in reocclusion following thrombolytic therapy or following an acute intervention, a pharmaceutical composition consisting of N-(5-chlorosalicyloyl)-8-aminocaprylic acid (5-CNAC), or a pharmaceutically acceptable salt thereof, in an amount effective to inhibit platelet aggregation and at least one of a pH adjuster, a preservative, a flavorant; a taste-masking agent; a fragrance; a humectant; a tonicifier; a colorant; a surfactant; a plasticiser; a lubricant; a flow aid; a compression aid; a solubilizer; an excipient; a diluent; a phosphate buffer salt; citric acid, glycol, a dispersing agent, crospovidone, or povidone.